Trial Profile
A multicenter, parallel group flexible dose study with a double blind, randomized, placebo controlled phase and an open-label phase to evaluate the quality of erections in men with erectile dysfunction treated with sildenafil citrate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Pfizer
- 16 Jan 2013 New source identified and integrated (German Clinical Trials Register record: DRKS00004151).
- 01 Mar 2008 Results have been published in The Journal of Sexual Medicine.
- 10 Aug 2006 Status change